Washington D.C.’s most powerful drug industry trade group this week ramped up its attacks on the 340B program, launching what’s [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
A New Jersey-based pharmaceutical manufacturer recently became the 39th drugmaker to enact 340B contract pharmacy restrictions. Mitsubishi Tanabe Pharma America [...] …
The 340B program continued to garner strong lobbying attention on Capitol Hill this spring, despite Congress’ focus on a GOP-backed [...] …
Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...] …
An Indiana-based pharmaceutical giant recently announced that it’s working to align its U.S. drug prices with those paid by other [...] …
A Swiss pharmaceutical giant this week announced new 340B contract pharmacy restriction exemptions for two states that recently enacted contract [...] …
The dark money group behind a campaign targeting GOP-led states’ efforts to enact 340B contract pharmacy access laws recently released [...] …
Trade groups representing 340B hospitals and hospital pharmacists recently urged the Health Resources and Services Administration (HRSA) to extend the [...] …
Two major drugmakers recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access [...] …
The Health Resources and Services Administration (HRSA) recently announced that a Texas health system’s location has been removed from the [...] …